K160246

Substantially Equivalent

SimulCare II(TM)

Applicant: Xanacare Technologies, LLC
Product code: GZJ
Advisory panel: Neurology
Date received: 2016-02-01
Decision date: 2016-10-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Denver, CO, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.